GlobeNewswire
Global Prefilled Syringes Industry
ReportLinker
27 min read

Global Prefilled Syringes Market to Reach $10. 1 Billion by 2027. Amid the COVID-19 crisis, the global market for Prefilled Syringes estimated at US$5. 6 Billion in the year 2020, is projected to reach a revised size of US$10.

New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Prefilled Syringes Industry" - https://www.reportlinker.com/p05799418/?utm_source=GNW
1 Billion by 2027, growing at a CAGR of 8.7% over the analysis period 2020-2027. Single-Chamber, one of the segments analyzed in the report, is projected to record a 10% CAGR and reach US$4.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Dual-Chamber segment is readjusted to a revised 8.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 11.7% CAGR

The Prefilled Syringes market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2027 trailing a CAGR of 11.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 7.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Customized Segment to Record 7.2% CAGR

In the global Customized segment, USA, Canada, Japan, China and Europe will drive the 6.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$1.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.4 Billion by the year 2027, while Latin America will expand at a 8.5% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 365-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Baxter International, Inc.

  • Becton, Dickinson and Company

  • Gerresheimer AG

  • Medtronic PLC

  • SCHOTT AG

  • Stevanato Group Company

  • Terumo Corporation

  • Unilife Corporation

  • Vetter Pharma International GmbH

  • West Pharmaceutical Services, Inc.

Terms and Privacy Policy
Your Privacy Choices
Utah Privacy Notice
More Info

Recommended Stories